NEW YORK, January 29, 2012 – United States Steel Corporation (NYSE: X) declined 0.04% to $23.71. The Company released fourth quarter and year end results. The net loss was $124 million or $0.86 per diluted share in 2012 versus net loss of $53 million or $0.37 per diluted share in 2011. The net loss was $50 million or $0.35 per diluted share compared to net loss of $211 million or $1.46 per diluted share in the fourth quarter of 2011.
Will X Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here http://beststocksdaily.com/p2/index.php?company=X
Kulicke and Soffa Industries Inc (NASDAQ: KLIC) slipped 9.96% to $11.57 on a traded volume of 1.54 million shares. The Company posted first quarter net income of $3.60 million or $0.05 per share compared to $8.51 million or $0.11 per share in the prior year period. The analysts expected the company to report first-quarter profit per share of $0.06. Net revenue was $114.04 million compared to $120.02 million last year. Analysts expected revenue of $107.24 million for the quarter. The Company expects net revenue in the second quarter to be approximately $90 million to $100 million. Analysts expect the company to report second-quarter revenue of $126.97 million.
How Should Investors Trade KLIC After The Recent Momentum, Find Out Here http://beststocksdaily.com/p2/index.php?company=KLIC
POSCO (ADR) (NYSE: PKX) increased 0.87% to $82.79 on a traded volume of 48k shares. In the last one year, the stock is down over 13%. The 52-week range for the stock is $71.32 and $95.27.
Get Free Special Trend Analysis On PKX Here http://beststocksdaily.com/p2/index.php?company=PKX
Keryx Biopharmaceuticals (NASDAQ: KERX) escalated 35.37% to $8.19. The stock is up after a successful late-stage study of its kidney-disease drug Zerenex also showed the surprise benefit of significantly reducing the use of costly anemia treatments. The results of Zerenex's Phase 3 trial showed the oral treatment not only was successful in lowering phosphate levels in patients with end-stage kidney disease but that it also reduced the use of intravenous iron by 52%.
Get Free Special Trend Analysis On KERX Here http://beststocksdaily.com/p2/index.php?company=KERX
Vale SA (ADR) (NYSE: VALE) moved up 0.62% to $19.47 on a traded volume of 5.53 million shares. Vale has been restated by TheStreet Ratings as a hold with a ratings score of C+.
Get Free Special Trend Analysis On VALE Here http://beststocksdaily.com/p2/index.php?company=VALE
Peabody Energy Corporation (NYSE: BTU) augmented 5.84% to $26.62 on a traded volume of 4.99 million shares. The Company reported fourth quarter net loss of $1.01 billion or $3.78 per share compared to net income of $222.4 million or $0.82 per share in the previous year period. The adjusted loss from continuing operations for the quarter was $295.2 million compared to net income of $237.5 million in the year ago quarter. Analysts expected the company to report earnings of $0.25 per share for the quarter. Revenue for the quarter was $2.02 billion compared to $2.23 billion in the prior year quarter. The analysts had consensus revenue estimate of $1.93 billion for the quarter.
Get Free Special Trend Analysis On BTU Here http://beststocksdaily.com/p2/index.php?company=BTU
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
1419 Westwood Blvd Los Angeles, CA